Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > back to before
View:
Post by thedave2006 on May 09, 2016 3:07pm

back to before

rumours of blackstone......mmmmm.
Comment by puma1 on May 09, 2016 3:10pm
big Bloomberg interview with the Blackstone CEO - linked to it from Andy McCreath. t heir target - 10% unlevered is the baseline and CXR has an unlevered EBITDA of $625 m plus. they said doing $5 b deals is a good fit.
Comment by visionaryfool on May 09, 2016 3:13pm
I really hope its not $5.0B EV :(. That' would put the CAD price at something like $40..... by my rough calculations. We need it at $6.0B or higher IMO.
Comment by puma1 on May 09, 2016 3:23pm
well 10% on that ebitda would take it to the $US 6 billion - $US 50 a share after backing out rough debt.
Concordia Healthcare Corp.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities